Literature DB >> 17203068

Botulinum neurotoxin B-host receptor recognition: it takes two receptors to tango.

Michael R Baldwin, Jung-Ja P Kim, Joseph T Barbieri.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17203068     DOI: 10.1038/nsmb0107-9

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


× No keyword cloud information.
  12 in total

1.  Recombinant holotoxoid vaccine against botulism.

Authors:  Christina L Pier; William H Tepp; Marite Bradshaw; Eric A Johnson; Joseph T Barbieri; Michael R Baldwin
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

2.  Botulinum neurotoxin is shielded by NTNHA in an interlocked complex.

Authors:  Shenyan Gu; Sophie Rumpel; Jie Zhou; Jasmin Strotmeier; Hans Bigalke; Kay Perry; Charles B Shoemaker; Andreas Rummel; Rongsheng Jin
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

3.  The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.

Authors:  B Vijayalakshmi Ayyar; K Roger Aoki; M Zouhair Atassi
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

4.  Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.

Authors:  Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

Review 5.  Assembly and function of the botulinum neurotoxin progenitor complex.

Authors:  Shenyan Gu; Rongsheng Jin
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

6.  Unique ganglioside recognition strategies for clostridial neurotoxins.

Authors:  Marc A Benson; Zhuji Fu; Jung-Ja P Kim; Michael R Baldwin
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

7.  Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.

Authors:  M Zouhair Atassi; Midori Taruishi; Masooma Naqvi; Lance E Steward; K Roger Aoki
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

Review 8.  Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins.

Authors:  Katerina Capková; Nicholas T Salzameda; Kim D Janda
Journal:  Toxicon       Date:  2009-03-25       Impact factor: 3.033

Review 9.  Towards new uses of botulinum toxin as a novel therapeutic tool.

Authors:  Andy Pickett; Karen Perrow
Journal:  Toxins (Basel)       Date:  2011-01-12       Impact factor: 4.546

10.  Weak glycolipid binding of a microdomain-tracer peptide correlates with aggregation and slow diffusion on cell membranes.

Authors:  Tim Lauterbach; Manoj Manna; Maria Ruhnow; Yudi Wisantoso; Yaofeng Wang; Artur Matysik; Kamila Oglęcka; Yuguang Mu; Susana Geifman-Shochat; Thorsten Wohland; Rachel Kraut
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.